Analysis of viral counter regulation against host's defense mechanism for viral infection using HCV transgenic mouse model
Analysis of viral counter regulation against host's defense mechanism for viral infection using HCV transgenic mouse model
批准号:
09470088
负责人:
WAKITA Takaji
金额:
$6.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Missing of proper culture system and animal model has hampered fine analysis of viral life cycle and pathogenesis of HCV infection. We established HCV transgenic mouse model using Cre/loxP switching system. We put neomycin resistance gene as a stuffer flanked by loxP sequence at both 5' and 3' end between CAG promoter and core to NS2, HCV cDNA CN2. Spleens were harvested from CN2 transgenic mice. In 2 lineages out of 8, cultured spleen cell and fibroblast highly expressed core, E1 and E2 proteins by western blot and immunostaining after infection with recombinant adeno virus (AxCANCre) which express cre DNA recombinase in infected cell. To induce HCV expression in vivo and in the liver, we injected AxCANCre to CN2 transgenic mouse from tail vein and HCV protein expression was confirmed in its liver tissue. With the expression of HCV structural protein, acute liver injury which was similar to human acute viral hepatitis was occurred. It was accompanied with apoptotic liver cell death. Serum core protein was detected in transgenic mice 7 days after AxCANCre injection with evident serum ALT elevations, subsequently, anti-core antibody response was detected at 14 days after infection. Furthermore, CD4 and CD8 positive cell depletion assay normalized the serum ALT elevations of mice and pathological changes in the liver. These results suggest that HCV proteins are not direct cytopathic and the host immune response has a pivotal roles in HCV infection. This transgenic mouse model system allows us to analyze the functions of viral products and host immune system in HCV infection and hepatocellular carcinogenesis of HCV.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Wakita T et al: "Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression." J.Med.Virol.57. 217-222 (1999)
Wakita T 等人:“反义 RNA 对丙型肝炎病毒 RNA 翻译和表达的抗病毒作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T Tanaka et al: "Acute hepatitis caused by sexual or household transmission of GBV-C J." Hepatology. 27. 1110-1112 (1997)
T Tanaka 等人:“GBV-C J 性传播或家庭传播引起的急性肝炎。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kase, R et al: "Immunohistochemical characterization of transgenic mice highly expressing human lysosomal alpha-galactosidase" Biochim.Biophys.Acta. 1406. 260-266 (1998)
Kase, R 等人:“高表达人溶酶体 α-半乳糖苷酶的转基因小鼠的免疫组织化学特征”Biochim.Biophys.Acta。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sato-M et al: "Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7" FEBS-Lett. 441. 106-10 (1998)
Sato-M 等人:“IFN 诱导转录因子 IRF-7 对 I 型 IFN 基因的正反馈调节”FEBS-Lett。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kondo S.et al: "Antisense telomerase treatment ; induction of two distinct pathways, apoptosis and differentiation." FASEB J.12. 801-811 (1998)
Kondo S.等人:“反义端粒酶治疗;诱导两种不同的途径:细胞凋亡和分化。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 75 条
Analysis of hepatitis C virus sequence quasi species by NGS
-
批准号:23659407
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:WAKITA Takaji
-
依托单位:
Cell culture system for genotype1b hepatitis C virus
-
批准号:21390235
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2009
-
负责人:WAKITA Takaji
-
依托单位:
Analysis of factors involved in viral replication efficiency and search for novel anti -virals using HCV culture systems.
-
批准号:18390225
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.58万
-
财政年份:2006
-
负责人:WAKITA Takaji
-
依托单位:
Analysis of replication of Hepatitis C Virus using highly efficient replication system
-
批准号:16590653
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2004
-
负责人:WAKITA Takaji
-
依托单位:
Construction and analysis of viral hepatocarcinogenesis model using HCV transgenic mouse model
-
批准号:14570531
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2002
-
负责人:WAKITA Takaji
-
依托单位:
Construction and analysis of viral hepatocarcinogenesis model using HCV transgenic mouse model
-
批准号:11670557
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:WAKITA Takaji
-
依托单位:
海外基金